Regulators should apply PP (precautionary principle) with care:
This article was originally published in Clinica
Executive Summary
Is the precautionary principle, which allows member states to withdraw devices from their markets, compatible with scientific and technological progress? This is a question the medical devices industry has been encouraged to ponder. Research Commissioner at the European Commission, Philippe Busquin, said that some regulatory authorities are too zealous in applying this instrument. They should carefully analyse the degree of risk and then introduce proportionate measures that put the degree of risk and interest into perspective, he said in a speech to the Free University of Brussels at the end of March. He also proposed that there should be the possibility to review measures in the light of further information and transparency.